- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Diagnostic Imaging's A Look Ahead: May 24 to May 30, 2021
Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
The Society for Imaging Informatics in Medicine is holding its 2021 Virtual Annual meeting this week. Look for our ongoing coverage of research and educational sessions from the conference.
For more SIIM 2021 Virtual Annual Meeting coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
COVID-19 has changed the way the industry has leveraged consumer technologies. From smartphones to gaming video cards to QR codes, Paul Shumway, vice president from Novarad, offers insights on the possibilities present with existing technologies.
For technology coverage, click here.
Women do not always mention breast pain or complications to their primary care provider or gynecologist first. In many instances, these women end up in the emergency department. However, that setting isn’t necessarily the best equipped for evaluating the breast. In an article published in the Journal of Breast Imaging, investigators analyze the outcomes experienced when women seek care in an emergency environment. Look for our coverage this week.
For other content on breast imaging and emergency care, click here.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
Mammography-Based AI Abnormality Scoring May Improve Prediction of Invasive Upgrade of DCIS
April 9th 2024Emerging research suggests that an artificial intelligence (AI) score of 75 or greater for mammography abnormalities more than doubles the likelihood of invasive upgrade of ductal carcinoma in situ (DCIS) diagnosed with percutaneous biopsy.
